Published in J Thorac Cardiovasc Surg on October 01, 1982
Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt. Br Heart J (1994) 0.79
Effect of prostacyclin on vascular capacity in the dog. J Clin Invest (1985) 0.78
A prospective study of the clinical benefits of prostacyclin in 554 cardiopulmonary bypass procedures. Tex Heart Inst J (1988) 0.75
Pathophysiology of brain damage during open-heart surgery. Tex Heart Inst J (1986) 0.75
Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg (1999) 7.29
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
Photoreceptor protein from the purple membrane of Halobacterium halobium. Molecular weight and retinal binding site. Biochemistry (1976) 3.08
The present role of coronary artery surgery. Practitioner (1982) 3.08
Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am (1996) 2.37
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg (1990) 2.07
Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart (2001) 1.93
Fibrin degradation products in normal and abnormal pregnancy and parturition. Br Med J (1969) 1.92
SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest (1988) 1.90
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med (2001) 1.82
Heparin-induced platelet dysfunction and cardiopulmonary bypass. Ann Thorac Surg (2000) 1.75
Molecular cloning of a member of the gene family that encodes pMGA, a hemagglutinin of Mycoplasma gallisepticum. Infect Immun (1993) 1.75
Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation. Thromb Haemost (1994) 1.67
Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg (1993) 1.66
Emergency surgery for stab wounds to the heart. Ann R Coll Surg Engl (1983) 1.57
A new porcine bioprosthesis: in vitro and in vivo evaluation. Life Support Syst (1985) 1.55
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. J Biol Chem (1987) 1.54
Fibrinolytic enhancement by stanozolol: a double blind trial. Br J Haematol (1972) 1.53
Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems. EMBO J (1989) 1.52
Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50
In vitro calcification of bioprosthetic heart valves: report of a novel method and review of the biochemical factors involved. J Heart Valve Dis (1992) 1.45
Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost (2004) 1.44
Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol (2001) 1.44
Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy. Lancet (1998) 1.43
Plasma albumin and haemodilution: the problem of interpretation in sequential studies. Ann Clin Biochem (1989) 1.42
The organisation of the multigene family which encodes the major cell surface protein, pMGA, of Mycoplasma gallisepticum. FEBS Lett (1994) 1.41
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem (1986) 1.41
Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight. Lancet (1999) 1.40
Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart (2003) 1.39
Respiratory dysfunction following cardiopulmonary bypass: verification of a non-invasive technique to measure shunt fraction. Respir Med (1993) 1.38
Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost (1997) 1.37
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Expression studies on four members of the pMGA multigene family in Mycoplasma gallisepticum S6. Microbiology (1995) 1.36
Characterization of a major hemagglutinin protein from Mycoplasma gallisepticum. Infect Immun (1992) 1.35
Blood loss with knee joint replacement. J R Coll Surg Edinb (1981) 1.33
Expression of the pMGA genes of Mycoplasma gallisepticum is controlled by variation in the GAA trinucleotide repeat lengths within the 5' noncoding regions. Infect Immun (1998) 1.31
Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell Commun Adhes (2001) 1.31
Prevalence of protein C deficiency in the healthy population. Thromb Haemost (1995) 1.28
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Mycoplasma synoviae has two distinct phase-variable major membrane antigens, one of which is a putative hemagglutinin. Infect Immun (1997) 1.26
Expression of two members of the pMGA gene family of Mycoplasma gallisepticum oscillates and is influenced by pMGA-specific antibodies. Infect Immun (1998) 1.25
Endocarditis as a manifestation of Chlamydia B infection (psittacosis). Br Heart J (1977) 1.24
Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br Med J (1972) 1.24
Traumatic rupture of the ascending aorta and aortic valve following blunt chest trauma. J Thorac Cardiovasc Surg (1977) 1.23
A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol (2001) 1.22
Contact sensitivity to azobenzenearsonate and its inhibition after interaction of sensitized cells with antigen-conjugated cells. J Exp Med (1981) 1.22
SP-40,40 is an inhibitor of C5b-6-initiated haemolysis. Int Immunol (1989) 1.17
The murine Fc receptor for immunoglobulin: purification, partial amino acid sequence, and isolation of cDNA clones. Proc Natl Acad Sci U S A (1986) 1.17
Disordered "fibrinolytic potential" in coronary heart disease. Thromb Res (1977) 1.16
Prevalence of antithrombin deficiency in the healthy population. Br J Haematol (1994) 1.13
Human seminal clusterin (SP-40,40). Isolation and characterization. J Clin Invest (1990) 1.12
Myocardial infarction caused by coronary artery damage from blunt chest injury. Br Heart J (1987) 1.11
'Last-ditch' use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang (2004) 1.08
Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction. Thromb Haemost (1984) 1.08
Are dependency and self-criticism risk factors for major depressive disorder? Can J Psychiatry (1997) 1.07
Penetrating cardiac injuries in the United Kingdom. Thorax (1983) 1.07
Plasminogen-activator-producing tumour. Br Med J (1969) 1.07
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology. J Clin Pathol (1993) 1.06
Characterization of a 95,000 molecule on sheep leucocytes homologous to murine Pgp-1 and human CD44. Immunology (1988) 1.06
Coronary surgery in Europe: comparison of the national subsets of the European system for cardiac operative risk evaluation database. Eur J Cardiothorac Surg (2000) 1.06
Freeze dried cryoprecipitate: a clinical evaluation. J Clin Pathol (1983) 1.04
Evaluation of an automated prothrombin assay using a chromogenic substrate. Haemostasis (1984) 1.04
A real time 2-dimensional ultrasonic scanner for clinical use. Ultrasonics (1976) 1.04
pMGA phenotypic variation in Mycoplasma gallisepticum occurs in vivo and is mediated by trinucleotide repeat length variation. Infect Immun (2000) 1.03
Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost (1998) 1.03
The keratin chains of avian scale tissue. Sequence heterogeneity and the number of scale keratin genes. Eur J Biochem (1976) 1.02
Induction of delayed-type hypersensitivity to azobenzenearsonate by a monoclonal anti-idiotype antibody. J Exp Med (1981) 1.02
The acute abdomen following cardiopulmonary bypass surgery. Br J Surg (1980) 1.02
Multiple extra-medullary plasmacytomas of the skin. Case report with a note on prognosis. Br J Dermatol (1974) 1.02
Two-dimensional echocardiography with a wide angle (60 degrees) sector scanner. Br Heart J (1977) 1.01
Anomalous origin of the left coronary artery from the pulmonary artery with coronary artery steal in adults. Report of two cases and review of the literature. Thorax (1976) 1.00
The management of ventricular septal rupture following myocardial infarction. Q J Med (1980) 0.99
Jaundice induced by stanozolol hypersensitivity. Postgrad Med J (1976) 0.99
Immunoglobulin Cmu RNA in T lymphoma cells is not translated. Nature (1980) 0.98
Ladder beam and camera video recording system for evaluating forelimb and hindlimb deficits after sensorimotor cortex injury in rats. J Neurosci Methods (1997) 0.98
The W and L allelic forms of phenylalanine hydroxylase in the rat differ by a threonine to isoleucine substitution. Biochem J (1986) 0.98
The immunoreactive 116 kDa surface protein of Mycoplasma pneumoniae is encoded in an operon. Microbiology (1997) 0.97
Differentiation between gaseous and formed embolic materials in vivo. Application in prosthetic heart valve patients. Stroke (1994) 0.97
Australia antigen in west of Scotland and north of England. Lancet (1970) 0.97
Allelic forms of beta 2-microglobulin in the mouse. Proc Natl Acad Sci U S A (1980) 0.96
SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges. FEBS Lett (1992) 0.96
Identification of Mycoplasma synoviae immunogenic surface proteins and their potential use as antigens in the enzyme-linked immunosorbent assay. Avian Dis (1996) 0.96
Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol (2000) 0.95
Comparison of thymic and peripheral T cell Ly-2/3 antigens. Eur J Immunol (1984) 0.95
Ly antigens associated with T cell recognition and effector function. Immunol Rev (1984) 0.94
The subunits of rabbit-muscle phosphofructokinase. A search for sequence repetition. Eur J Biochem (1976) 0.93
The amino-terminal sequences of Ly-2 and Ly-3. Immunogenetics (1986) 0.92
Coronary artery disease patients' perception of their health and expectations of benefit following coronary artery bypass grafting. J Adv Nurs (2000) 0.92
The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues. Biochem J (1994) 0.92
Traumatic brain injury of the forelimb and hindlimb sensorimotor areas in the rat: physiological, histological and behavioral correlates. Behav Brain Res (1996) 0.92